Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus

Amyloid

Volumn 16, Issue 1, 2009, Pages 32-37

  Dardiotis, Eftymioe ^a,d   Koutsou, Panoelitsa ^a   Papanicolaou, Eleni Zamba ^a   Vonta, Ilia ^b   Kladi, Athina ^c   Vassilopoulos, Demetrios ^c   Hadjigeorgiou, Georgios ^d   Christodoulou, Kyproyla ^a   Kyriakides, Theodoros ^a  

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^b UNIVERSITY OF CYPRUS   (Cyprus)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^d INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

Author keywords

Epidemiology; Familial amyloidotic neuropathy; Transthyretin

Indexed keywords

PREALBUMIN;

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL FEATURE; CYPRUS; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; NUCLEOTIDE SEQUENCE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; SENSORIMOTOR NEUROPATHY; ADOLESCENT; GENETICS; HETEROZYGOTE DETECTION; MIDDLE AGED;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AMYLOID NEUROPATHIES, FAMILIAL; CYPRUS; FEMALE; HETEROZYGOTE DETECTION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREALBUMIN; PREVALENCE;

EID: 65449119979     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120802676948     Document Type: Article

References (29)

1. Hou X, Aguilar MI, Small DH. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FEBS J 2007;274:1637-1650.
2. Plante-Bordeneuve V, Said G. Transthyretin related familial amyloid polyneuropathy. Curr Opin Neurol 2000;13:569-573.
3. Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408-427.
4. Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl 1976;590:1-64.
5. Sakoda S, Suzuki T, Higa S, Ueji M, Kishimoto S, Hayashi A, Yasuda N, Takaba Y, Nakajima A. Genetic studies of familial amyloid polyneuropathy in the Arao district of Japan: I. The genealogical survey. Clin Gen 1983;24:334-338.
6. Bittencourt PL, Couto CA, Clemente C, Farias AQ, Palacios SA, Mies S, Goldberg AC. Phenotypic expression of familial amyloid polyneuropathy in Brazil. Eur J Neurol 2005;12:289-293.
7. Munar-Ques M, Saraiva MJ, Viader-Farre C, Zabay-Becerril JM, Mulet-Ferrer J. Genetic epidemiology of familial amyloid polyneuropathy in the Balearic Islands (Spain). Amyloid: J Protein Fold Dis 2005;12:54-61.
8. Coelho T. Familial amyloid polyneuropathy: new developments in genetics and treatment. Curr Opin Neurol 1996; 9:355-359.
9. Misu K, Hattori N, Nagamatsu M, Ikeda S, Ando Y, Nakazato M, Takei Y, Hanyu N, Usui Y, Tanaka F, Harada T, Inukai A, Hashizume Y, Sobue G. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 1999;122(Pt 10):1951-1962.
10. Tashima K, Ando Y, Ando E, Tanaka Y, Ando M, Uchino M. Heterogeneity of clinical symptoms in patients with familial amyloidotic polyneuropathy (FAP TTR Met30). Amyloid: The Int J Exp Clin Invest 1997;4:108-111.
11. Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 1993;43:288-294.
12. Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 1995;60:512-521.
13. Holt IJ, Harding AE, Middleton L, Chrysostomou G, Said G, King RH, Thomas PK. Molecular genetics of amyloid neuropathy in Europe. Lancet 1989;1:524-526.
14. Holmgren G, Costa PM, Andersson C, Asplund K, Steen L, Beckman L, Nylander PO, Teixeira A, Saraiva MJ, Costa PP. Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Gen 1994;31:351-354.
15. Drugge U, Andersson R, Chizari F, Danielsson M, Holmgren G, Sandgren O, Sousa A. Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis. J Med Genet 1993;30:388-392.
16. Yoshioka K, Furuya H, Sasaki H, Saraiva MJ, Costa PP, Sakaki Y. Haplotype analysis of familial amyloidotic poly-neuropathy. Evidence for multiple origins of the Val-Met mutation most common to the disease. Hum Genet 1989; 82:9-13.
17. Ohmori H, Ando Y, Makita Y, Onouchi Y, Nakajima T, Saraiva MJ, Terazaki H, Suhr O, Sobue G, Nakamura M, Yamaizumi M, Munar-Ques M, Inoue I, Uchino M, Hata A. Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy. J Med Genet 2004;41:e51.
18. Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002;58:1001-1007.
19. Conceicao I, De Carvalho M. Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal. Muscle Nerve 2007;35:116-118.
20. Araki S, Mawatari S, Ohta M, Nakajima A, Kuroiwa Y. Polyneuritic amyloidosis in a Japanese family. Arch Neurol 1968;18:593-602.
21. Kito S, Itoga E, Kamiya K, Kishida T, Yamamura Y. Studies on familial amyloid polyneuropathy in Ogawa Village, Japan. Eur Neurol 1980;19:141-151.
22. Reilly MM, Adams D, Davis MB, Said G, Harding AE. Haplotype analysis of French, British and other European patients with familial amyloid polyneuropathy (met 30 and tyr 77). J Neurol 1995;242:664-668.
23. Almeida MR, Aoyama-Oishi N, Sakaki Y, Holmgren G, Ulf D, Ferlini A, Salvi F, Munar-Oues M, Benson MD, Skinner M, Costa PP, Saraiva MJ. Haplotype analysis of common transthyretin mutations. Hum Genet 1995;96:350-354.
24. Koike H, Misu U, Ikeda S, Ando Y, Nakazato M, Ando E, Yamamoto M, Hattori N, Sobue G. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs. late-onset form. Arch Neurol 2002;59:1771-1776.
25. Misu K, Hattori N, Ando Y, Ikeda S, Sobue G. Anticipation in early- but not late-onset familial amyloid polyneuropathy (TTR met 30) in Japan. Neurology 2000; 55:451-452.
26. Soares M, Buxbaum J, Sirugo G, Coelho T, Sousa A, Kastner D, Saraiva MJ. Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions. Hum Genet 1999;104:480-485.
27. Yamamoto K, Ikeda S, Hanyu N, Takeda S, Yanagisawa N. A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. J Med Genet 1998;35: 23-30.
28. Soares ML, Coelho T, Sousa A, Batalov S, Conceicao I, Sales-Luis ML, Ritchie MD, Williams SM, Nievergelt CM, Schork NJ, Saraiva MJ, Buxbaum JN. Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease. Hum Mol Genet 2005;14:543-553.
29. Croce CM. Oncogenes and cancer. N Engl J Med 2008; 358:502-511.